{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:12:31Z","timestamp":1793243551819,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.leukres.2024.107437","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T04:49:35Z","timestamp":1704775775000},"page":"107437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Artificial intelligence-based prediction models for acute myeloid leukemia using real-life data: A DATAML registry study"],"prefix":"10.1016","volume":"136","author":[{"given":"Ibrahim","family":"Didi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Alliot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Yves","family":"Dumas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Vergez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Tavitian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"La\u00ebtitia","family":"Largeaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Bidet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Rieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Luquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Lechevalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Delabesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Sarry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Charlotte","family":"De Grande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"B\u00e9rard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Pigneux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"R\u00e9cher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Simoncini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Bertoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.leukres.2024.107437_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-017-0011-1","article-title":"Improved outcome for AML patients over the years 2000-2014","volume":"7","author":"Bertoli","year":"2017","journal-title":"Blood Cancer J."},{"issue":"8","key":"10.1016\/j.leukres.2024.107437_bib2","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/cncr.33477","article-title":"Acute myeloid leukemia: treatment and research outlook for 2021 and the MD Anderson approach","volume":"127","author":"Kantarjian","year":"2021","journal-title":"Cancer"},{"issue":"20","key":"10.1016\/j.leukres.2024.107437_bib3","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107437_bib4","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 ELN recommendations from an international expert panel","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.leukres.2024.107437_bib5","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N. Engl. J. Med"},{"issue":"26","key":"10.1016\/j.leukres.2024.107437_bib6","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1182\/blood.2021013626","article-title":"2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party","volume":"138","author":"Heuser","year":"2021","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.leukres.2024.107437_bib7","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1056\/NEJMoa0901409","article-title":"Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON); German AML Study Group (AMLSG); Swiss Group for Clinical Cancer Research (SAKK) Collaborative Group. High-dose daunorubicin in older patients with acute myeloid leukemia","volume":"361","author":"L\u00f6wenberg","year":"2009","journal-title":"N. Engl. J. Med"},{"issue":"13","key":"10.1016\/j.leukres.2024.107437_bib8","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJMoa0904544","article-title":"Anthracycline dose intensification in acute myeloid leukemia","volume":"361","author":"Fernandez","year":"2009","journal-title":"N. Engl. J. Med"},{"issue":"32","key":"10.1016\/j.leukres.2024.107437_bib9","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1200\/JCO.2018.78.7366","article-title":"French innovative leukemia organization. improved survival by adding lomustine to conventional chemotherapy for elderly patients with AML without unfavorable cytogenetics: results of the LAM-SA 2007 FILO trial","volume":"36","author":"Pigneux","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.leukres.2024.107437_bib10","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1200\/JCO.2009.23.8329","article-title":"Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia","volume":"28","author":"Fenaux","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.leukres.2024.107437_bib11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1182\/blood-2015-01-621664","article-title":"International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts","volume":"126","author":"Dombret","year":"2015","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.leukres.2024.107437_bib12","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMoa1614359","article-title":"Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation","volume":"377","author":"Stone","year":"2017","journal-title":"N. Engl. J. Med"},{"issue":"7","key":"10.1016\/j.leukres.2024.107437_bib13","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2012971","article-title":"Azacitidine and venetoclax in previously untreated acute myeloid leukemia","volume":"383","author":"DiNardo","year":"2020","journal-title":"N. Engl. J. Med"},{"issue":"16","key":"10.1016\/j.leukres.2024.107437_bib14","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa2117344","article-title":"Ivosidenib and azacitidine in IDH1-mutated acute myeloid leukemia","volume":"386","author":"Montesinos","year":"2022","journal-title":"N. Engl. J. Med"},{"issue":"18","key":"10.1016\/j.leukres.2024.107437_bib15","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1056\/NEJMoa1902688","article-title":"Gilteritinib or chemotherapy for relapsed or refractory FLT3-mutated AML","volume":"381","author":"Perl","year":"2019","journal-title":"N. Engl. J. Med"},{"issue":"26","key":"10.1016\/j.leukres.2024.107437_bib16","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1056\/NEJMoa2004444","article-title":"QUAZAR AML-001 trial investigators. Oral azacitidine maintenance therapy for acute myeloid leukemia in first remission","volume":"383","author":"Wei","year":"2020","journal-title":"N. Engl. J. Med"},{"issue":"7","key":"10.1016\/j.leukres.2024.107437_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41408-022-00700-x","article-title":"A scoring system for AML patients aged 70 years or older, eligible for intensive chemotherapy: a study based on a large European data set using the DATAML, SAL, and PETHEMA registries","volume":"12","author":"B\u00e9rard","year":"2022","journal-title":"Blood Cancer J."},{"issue":"3","key":"10.1016\/j.leukres.2024.107437_bib18","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/blood-2009-11-254441","article-title":"Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials","volume":"116","author":"Grimwade","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107437_bib19","doi-asserted-by":"crossref","first-page":"850","DOI":"10.18632\/oncotarget.347","article-title":"Do AML patients with DNMT3A exon 23 mutations benefit from idarubicin as compared to daunorubicin? A single center experience","volume":"2","author":"LaRochelle","year":"2011","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.leukres.2024.107437_bib20","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/s41375-020-01031-1","article-title":"French Innovative Leukemia Organization (FILO). Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study","volume":"35","author":"Largeaud","year":"2021","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.leukres.2024.107437_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-021-00601-5","article-title":"Genomic landscape of hyperleukocytic acute myeloid leukemia","volume":"12","author":"Largeaud","year":"2022","journal-title":"Blood Cancer J."},{"issue":"12","key":"10.1016\/j.leukres.2024.107437_bib22","doi-asserted-by":"crossref","first-page":"E244","DOI":"10.1002\/ajh.23848","article-title":"Intensive chemotherapy, azacitidine, or supportive care in older acute myeloid leukemia patients: an analysis from a regional healthcare network","volume":"89","author":"Bories","year":"2014","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.leukres.2024.107437_bib23","article-title":"Long-term survival after intensive chemotherapy or hypomethylating agents in AML patients aged 70 years and older: a large patient data set study from European registries","author":"R\u00e9cher","year":"2021","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.leukres.2024.107437_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-021-00551-y","article-title":"Intermediate-dose cytarabine or standard-dose cytarabine plus single-dose anthracycline as post-remission therapy in older patients with acute myeloid leukemia: impact on health care resource consumption and outcomes","volume":"11","author":"Galtier","year":"2021","journal-title":"Blood Cancer J."},{"issue":"16","key":"10.1016\/j.leukres.2024.107437_bib25","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1182\/bloodadvances.2020002511","article-title":"Delivering HDAC over 3 or 5 days as consolidation in AML impacts health care resource consumption but not outcome","volume":"4","author":"Dumas","year":"2020","journal-title":"Blood Adv."},{"issue":"6","key":"10.1016\/j.leukres.2024.107437_bib26","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1080\/10428194.2021.2022140","article-title":"Azacitidine, intensive chemotherapy or best supportive care in relapsed or refractory acute myeloid leukemia, a DATAML registry study","volume":"63","author":"Gadaud","year":"2022","journal-title":"Leuk. Lymphoma"},{"issue":"3","key":"10.1016\/j.leukres.2024.107437_bib27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0885-064X(88)90020-9","article-title":"On the capabilities of multilayer perceptrons","volume":"vol. 4","author":"Baum","year":"1988","journal-title":"J. Complex."},{"key":"10.1016\/j.leukres.2024.107437_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i11","article-title":"Feature selection with the Boruta package","volume":"vol. 36","author":"Kursa","year":"2010","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.leukres.2024.107437_bib29","article-title":"A unified approach to interpreting model predictions","volume":"vol. 30","author":"Lundberg","year":"2017","journal-title":"Adv. Neural Inf. Process. Syst."},{"issue":"3","key":"10.1016\/j.leukres.2024.107437_bib30","article-title":"Acute myeloid leukemia and artificial intelligence, algorithms and new scores","volume":"33","author":"Radakovich","year":"2020","journal-title":"Best. Pr. Res Clin. Haematol."},{"issue":"23","key":"10.1016\/j.leukres.2024.107437_bib31","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1182\/bloodadvances.2020002997","article-title":"Application of machine learning in the management of acute myeloid leukemia: current practice and future prospects","volume":"4","author":"Eckardt","year":"2020","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.leukres.2024.107437_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261848","article-title":"WBC-AMNet: automatic classification of WBC images using deep feature fusion network based on focalized attention mechanism","volume":"17","author":"Wang","year":"2022","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.leukres.2024.107437_bib33","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1182\/blood.2020010568","article-title":"Highly accurate differentiation of bone marrow cell morphologies using deep neural networks on a large image data set","volume":"138","author":"Matek","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107437_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2021.105999","article-title":"A deep learning model (ALNet) for the diagnosis of acute leukaemia lineage using peripheral blood cell images","volume":"202","author":"Bold\u00fa","year":"2021","journal-title":"Comput. Methods Prog. Biomed."},{"key":"10.1016\/j.leukres.2024.107437_bib35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.medengphy.2021.10.006","article-title":"Automated detection of leukemia by pretrained deep neural networks and transfer learning: a comparison","volume":"98","author":"Anilkumar","year":"2021","journal-title":"Med Eng. Phys."},{"key":"10.1016\/j.leukres.2024.107437_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105236","article-title":"LeuFeatx: deep learning-based feature extractor for the diagnosis of acute leukemia from microscopic images of peripheral blood smear","volume":"142","author":"Rastogi","year":"2022","journal-title":"Comput. Biol. Med"},{"issue":"1","key":"10.1016\/j.leukres.2024.107437_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2019.100780","article-title":"Scalable prediction of acute myeloid leukemia using high-dimensional machine learning and blood transcriptomics","volume":"23","author":"Warnat-Herresthal","year":"2020","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.leukres.2024.107437_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-04835-6","article-title":"Blood cancer prediction using leukemia microarray gene data and hybrid logistic vector trees model","volume":"12","author":"Rupapara","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.leukres.2024.107437_bib39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41375-021-01408-w","article-title":"Deep learning detects acute myeloid leukemia and predicts NPM1 mutation status from bone marrow smears","volume":"36","author":"Eckardt","year":"2022","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.leukres.2024.107437_bib40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12885-022-09307-8","article-title":"Deep learning identifies Acute Promyelocytic Leukemia in bone marrow smears","volume":"22","author":"Eckardt","year":"2022","journal-title":"BMC Cancer"},{"issue":"13","key":"10.1016\/j.leukres.2024.107437_bib41","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1080\/10428194.2020.1798951","article-title":"Machine learning derived genomics driven prognostication for acute myeloid leukemia with RUNX1-RUNX1T1","volume":"61","author":"Shaikh","year":"2020","journal-title":"Leuk. Lymphoma"},{"issue":"19","key":"10.1016\/j.leukres.2024.107437_bib42","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1182\/blood.2021012455","article-title":"Machine learning finds new AML subtypes","volume":"138","author":"Thomas","year":"2021","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.leukres.2024.107437_bib43","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1182\/blood.2020010603","article-title":"Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemia","volume":"138","author":"Awada","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107437_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.145903","article-title":"Identification of biomarkers for acute leukemia via machine learning-based stemness index","volume":"804","author":"Zhang","year":"2021","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.leukres.2024.107437_bib45","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/ng.3756","article-title":"Precision oncology for acute myeloid leukemia using a knowledge bank approach","volume":"49","author":"Gerstung","year":"2017","journal-title":"Nat. Genet"},{"key":"10.1016\/j.leukres.2024.107437_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.657191","article-title":"Personalized survival prediction of patients with acute myeloblastic leukemia using gene expression profiling","volume":"11","author":"Mosquera Orgueira","year":"2021","journal-title":"Front Oncol."},{"issue":"3","key":"10.1016\/j.leukres.2024.107437_bib47","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/s41375-021-01435-7","article-title":"Machine learning identifies the independent role of dysplasia in the prediction of response to chemotherapy in AML","volume":"36","author":"Duchmann","year":"2022","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.leukres.2024.107437_bib48","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3324\/haematol.2021.280027","article-title":"Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning","volume":"108","author":"Eckardt","year":"2023","journal-title":"Haematologica"},{"issue":"Supplement_1","key":"10.1016\/j.leukres.2024.107437_bib49","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1182\/blood-2019-128243","article-title":"Use of machine learning in 2074 cases of acute myeloid leukemia for genetic risk profiling","volume":"134","author":"Fleming","year":"2019","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2024.107437_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41746-021-00549-7","article-title":"Guidelines and quality criteria for AIPM in healthcare: a scoping review","volume":"5","author":"De Hond","year":"2022","journal-title":"NPJ Digit Med"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212624000031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212624000031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:05:00Z","timestamp":1758935100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212624000031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":50,"alternative-id":["S0145212624000031"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2024.107437","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artificial intelligence-based prediction models for acute myeloid leukemia using real-life data: A DATAML registry study","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2024.107437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107437"}}